Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS)
Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data were collected via patient questionnaires (July 2020–March 2023) and genetic diagnoses from medical...
Ausführliche Beschreibung
Autor*in: |
Linda A. J. Hendricks [verfasserIn] Katja C. J. Verbeek [verfasserIn] Janneke H. M. Schuurs-Hoeijmakers [verfasserIn] Arjen R. Mensenkamp [verfasserIn] Hilde Brems [verfasserIn] Robin de Putter [verfasserIn] Violetta C. Anastasiadou [verfasserIn] Marie-Charlotte Villy [verfasserIn] Arne Jahn [verfasserIn] Verena Steinke-Lange [verfasserIn] Margherita Baldassarri [verfasserIn] Arvids Irmejs [verfasserIn] Mirjam M. de Jong [verfasserIn] Thera P. Links [verfasserIn] Edward M. Leter [verfasserIn] Daniëlle G. M. Bosch [verfasserIn] Hildegunn Høberg-Vetti [verfasserIn] Marianne Tveit Haavind [verfasserIn] Kjersti Jørgensen [verfasserIn] Lovise Mæhle [verfasserIn] Ana Blatnik [verfasserIn] Joan Brunet [verfasserIn] Esther Darder [verfasserIn] Emma Tham [verfasserIn] Nicoline Hoogerbrugge [verfasserIn] Janet R. Vos [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2024 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Cancers - MDPI AG, 2010, 16(2024), 5, p 953 |
---|---|
Übergeordnetes Werk: |
volume:16 ; year:2024 ; number:5, p 953 |
Links: |
---|
DOI / URN: |
10.3390/cancers16050953 |
---|
Katalog-ID: |
DOAJ091272653 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ091272653 | ||
003 | DE-627 | ||
005 | 20240413232928.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240412s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/cancers16050953 |2 doi | |
035 | |a (DE-627)DOAJ091272653 | ||
035 | |a (DE-599)DOAJfec7f542d3f149ddb920a8ada25386b8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC254-282 | |
100 | 0 | |a Linda A. J. Hendricks |e verfasserin |4 aut | |
245 | 1 | 0 | |a Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS) |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data were collected via patient questionnaires (July 2020–March 2023) and genetic diagnoses from medical files. Associations between lifestyle and breast cancer were calculated using logistic regression corrected for age. Index patients with breast cancer before PHTS diagnosis (breast cancer index) were excluded for ascertainment bias correction. In total, 125 patients were included who completed the questionnaire at a mean age of 44 years (SD = 13). This included 21 breast cancer indexes (17%) and 39 females who developed breast cancer at 43 years (SD = 9). Breast cancer patients performed about 1.1 times less often 0–1 times/week physical activity than ≥2 times (OR<sub<total-adj</sub< = 0.9 (95%CI 0.3–2.6); consumed daily about 1.2–1.8 times more often ≥1 than 0–1 glasses of alcohol (OR<sub<total-adj</sub< = 1.2 (95%CI 0.4–4.0); OR<sub<non-breastcancer-index-adj</sub< = 1.8 (95%CI 0.4–6.9); were about 1.04–1.3 times more often smokers than non-smokers (OR<sub<total-adj</sub< = 1.04 (95%CI 0.4–2.8); OR<sub<non-breastcancer-index-adj</sub< = 1.3 (95%CI 0.4–4.2)); and overweight or obesity (72%) was about 1.02–1.3 times less common (OR<sub<total-adj</sub< = 0.98 (95%CI 0.4–2.6); OR<sub<non-breastcancer-index-adj</sub< = 0.8 (95%CI 0.3–2.7)). Similar associations between lifestyle and breast cancer are suggested for PHTS and the general population. Despite not being statistically significant, results are clinically relevant and suggest that awareness of the effects of lifestyle on patients’ breast cancer risk is important. | ||
650 | 4 | |a alcohol drinking | |
650 | 4 | |a body mass index | |
650 | 4 | |a breast neoplasm | |
650 | 4 | |a exercise | |
650 | 4 | |a hamartoma syndrome | |
650 | 4 | |a multiple | |
653 | 0 | |a Neoplasms. Tumors. Oncology. Including cancer and carcinogens | |
700 | 0 | |a Katja C. J. Verbeek |e verfasserin |4 aut | |
700 | 0 | |a Janneke H. M. Schuurs-Hoeijmakers |e verfasserin |4 aut | |
700 | 0 | |a Arjen R. Mensenkamp |e verfasserin |4 aut | |
700 | 0 | |a Hilde Brems |e verfasserin |4 aut | |
700 | 0 | |a Robin de Putter |e verfasserin |4 aut | |
700 | 0 | |a Violetta C. Anastasiadou |e verfasserin |4 aut | |
700 | 0 | |a Marie-Charlotte Villy |e verfasserin |4 aut | |
700 | 0 | |a Arne Jahn |e verfasserin |4 aut | |
700 | 0 | |a Verena Steinke-Lange |e verfasserin |4 aut | |
700 | 0 | |a Margherita Baldassarri |e verfasserin |4 aut | |
700 | 0 | |a Arvids Irmejs |e verfasserin |4 aut | |
700 | 0 | |a Mirjam M. de Jong |e verfasserin |4 aut | |
700 | 0 | |a Thera P. Links |e verfasserin |4 aut | |
700 | 0 | |a Edward M. Leter |e verfasserin |4 aut | |
700 | 0 | |a Daniëlle G. M. Bosch |e verfasserin |4 aut | |
700 | 0 | |a Hildegunn Høberg-Vetti |e verfasserin |4 aut | |
700 | 0 | |a Marianne Tveit Haavind |e verfasserin |4 aut | |
700 | 0 | |a Kjersti Jørgensen |e verfasserin |4 aut | |
700 | 0 | |a Lovise Mæhle |e verfasserin |4 aut | |
700 | 0 | |a Ana Blatnik |e verfasserin |4 aut | |
700 | 0 | |a Joan Brunet |e verfasserin |4 aut | |
700 | 0 | |a Esther Darder |e verfasserin |4 aut | |
700 | 0 | |a Emma Tham |e verfasserin |4 aut | |
700 | 0 | |a Nicoline Hoogerbrugge |e verfasserin |4 aut | |
700 | 0 | |a Janet R. Vos |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Cancers |d MDPI AG, 2010 |g 16(2024), 5, p 953 |w (DE-627)614095670 |w (DE-600)2527080-1 |x 20726694 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2024 |g number:5, p 953 |
856 | 4 | 0 | |u https://doi.org/10.3390/cancers16050953 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/fec7f542d3f149ddb920a8ada25386b8 |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/16/5/953 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2072-6694 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 16 |j 2024 |e 5, p 953 |
author_variant |
l a j h lajh k c j v kcjv j h m s h jhmsh a r m arm h b hb r d p rdp v c a vca m c v mcv a j aj v s l vsl m b mb a i ai m m d j mmdj t p l tpl e m l eml d g m b dgmb h h v hhv m t h mth k j kj l m lm a b ab j b jb e d ed e t et n h nh j r v jrv |
---|---|
matchkey_str |
article:20726694:2024----::ietlfcosnbescneifmlsihtnaat |
hierarchy_sort_str |
2024 |
callnumber-subject-code |
RC |
publishDate |
2024 |
allfields |
10.3390/cancers16050953 doi (DE-627)DOAJ091272653 (DE-599)DOAJfec7f542d3f149ddb920a8ada25386b8 DE-627 ger DE-627 rakwb eng RC254-282 Linda A. J. Hendricks verfasserin aut Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS) 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data were collected via patient questionnaires (July 2020–March 2023) and genetic diagnoses from medical files. Associations between lifestyle and breast cancer were calculated using logistic regression corrected for age. Index patients with breast cancer before PHTS diagnosis (breast cancer index) were excluded for ascertainment bias correction. In total, 125 patients were included who completed the questionnaire at a mean age of 44 years (SD = 13). This included 21 breast cancer indexes (17%) and 39 females who developed breast cancer at 43 years (SD = 9). Breast cancer patients performed about 1.1 times less often 0–1 times/week physical activity than ≥2 times (OR<sub<total-adj</sub< = 0.9 (95%CI 0.3–2.6); consumed daily about 1.2–1.8 times more often ≥1 than 0–1 glasses of alcohol (OR<sub<total-adj</sub< = 1.2 (95%CI 0.4–4.0); OR<sub<non-breastcancer-index-adj</sub< = 1.8 (95%CI 0.4–6.9); were about 1.04–1.3 times more often smokers than non-smokers (OR<sub<total-adj</sub< = 1.04 (95%CI 0.4–2.8); OR<sub<non-breastcancer-index-adj</sub< = 1.3 (95%CI 0.4–4.2)); and overweight or obesity (72%) was about 1.02–1.3 times less common (OR<sub<total-adj</sub< = 0.98 (95%CI 0.4–2.6); OR<sub<non-breastcancer-index-adj</sub< = 0.8 (95%CI 0.3–2.7)). Similar associations between lifestyle and breast cancer are suggested for PHTS and the general population. Despite not being statistically significant, results are clinically relevant and suggest that awareness of the effects of lifestyle on patients’ breast cancer risk is important. alcohol drinking body mass index breast neoplasm exercise hamartoma syndrome multiple Neoplasms. Tumors. Oncology. Including cancer and carcinogens Katja C. J. Verbeek verfasserin aut Janneke H. M. Schuurs-Hoeijmakers verfasserin aut Arjen R. Mensenkamp verfasserin aut Hilde Brems verfasserin aut Robin de Putter verfasserin aut Violetta C. Anastasiadou verfasserin aut Marie-Charlotte Villy verfasserin aut Arne Jahn verfasserin aut Verena Steinke-Lange verfasserin aut Margherita Baldassarri verfasserin aut Arvids Irmejs verfasserin aut Mirjam M. de Jong verfasserin aut Thera P. Links verfasserin aut Edward M. Leter verfasserin aut Daniëlle G. M. Bosch verfasserin aut Hildegunn Høberg-Vetti verfasserin aut Marianne Tveit Haavind verfasserin aut Kjersti Jørgensen verfasserin aut Lovise Mæhle verfasserin aut Ana Blatnik verfasserin aut Joan Brunet verfasserin aut Esther Darder verfasserin aut Emma Tham verfasserin aut Nicoline Hoogerbrugge verfasserin aut Janet R. Vos verfasserin aut In Cancers MDPI AG, 2010 16(2024), 5, p 953 (DE-627)614095670 (DE-600)2527080-1 20726694 nnns volume:16 year:2024 number:5, p 953 https://doi.org/10.3390/cancers16050953 kostenfrei https://doaj.org/article/fec7f542d3f149ddb920a8ada25386b8 kostenfrei https://www.mdpi.com/2072-6694/16/5/953 kostenfrei https://doaj.org/toc/2072-6694 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 16 2024 5, p 953 |
spelling |
10.3390/cancers16050953 doi (DE-627)DOAJ091272653 (DE-599)DOAJfec7f542d3f149ddb920a8ada25386b8 DE-627 ger DE-627 rakwb eng RC254-282 Linda A. J. Hendricks verfasserin aut Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS) 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data were collected via patient questionnaires (July 2020–March 2023) and genetic diagnoses from medical files. Associations between lifestyle and breast cancer were calculated using logistic regression corrected for age. Index patients with breast cancer before PHTS diagnosis (breast cancer index) were excluded for ascertainment bias correction. In total, 125 patients were included who completed the questionnaire at a mean age of 44 years (SD = 13). This included 21 breast cancer indexes (17%) and 39 females who developed breast cancer at 43 years (SD = 9). Breast cancer patients performed about 1.1 times less often 0–1 times/week physical activity than ≥2 times (OR<sub<total-adj</sub< = 0.9 (95%CI 0.3–2.6); consumed daily about 1.2–1.8 times more often ≥1 than 0–1 glasses of alcohol (OR<sub<total-adj</sub< = 1.2 (95%CI 0.4–4.0); OR<sub<non-breastcancer-index-adj</sub< = 1.8 (95%CI 0.4–6.9); were about 1.04–1.3 times more often smokers than non-smokers (OR<sub<total-adj</sub< = 1.04 (95%CI 0.4–2.8); OR<sub<non-breastcancer-index-adj</sub< = 1.3 (95%CI 0.4–4.2)); and overweight or obesity (72%) was about 1.02–1.3 times less common (OR<sub<total-adj</sub< = 0.98 (95%CI 0.4–2.6); OR<sub<non-breastcancer-index-adj</sub< = 0.8 (95%CI 0.3–2.7)). Similar associations between lifestyle and breast cancer are suggested for PHTS and the general population. Despite not being statistically significant, results are clinically relevant and suggest that awareness of the effects of lifestyle on patients’ breast cancer risk is important. alcohol drinking body mass index breast neoplasm exercise hamartoma syndrome multiple Neoplasms. Tumors. Oncology. Including cancer and carcinogens Katja C. J. Verbeek verfasserin aut Janneke H. M. Schuurs-Hoeijmakers verfasserin aut Arjen R. Mensenkamp verfasserin aut Hilde Brems verfasserin aut Robin de Putter verfasserin aut Violetta C. Anastasiadou verfasserin aut Marie-Charlotte Villy verfasserin aut Arne Jahn verfasserin aut Verena Steinke-Lange verfasserin aut Margherita Baldassarri verfasserin aut Arvids Irmejs verfasserin aut Mirjam M. de Jong verfasserin aut Thera P. Links verfasserin aut Edward M. Leter verfasserin aut Daniëlle G. M. Bosch verfasserin aut Hildegunn Høberg-Vetti verfasserin aut Marianne Tveit Haavind verfasserin aut Kjersti Jørgensen verfasserin aut Lovise Mæhle verfasserin aut Ana Blatnik verfasserin aut Joan Brunet verfasserin aut Esther Darder verfasserin aut Emma Tham verfasserin aut Nicoline Hoogerbrugge verfasserin aut Janet R. Vos verfasserin aut In Cancers MDPI AG, 2010 16(2024), 5, p 953 (DE-627)614095670 (DE-600)2527080-1 20726694 nnns volume:16 year:2024 number:5, p 953 https://doi.org/10.3390/cancers16050953 kostenfrei https://doaj.org/article/fec7f542d3f149ddb920a8ada25386b8 kostenfrei https://www.mdpi.com/2072-6694/16/5/953 kostenfrei https://doaj.org/toc/2072-6694 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 16 2024 5, p 953 |
allfields_unstemmed |
10.3390/cancers16050953 doi (DE-627)DOAJ091272653 (DE-599)DOAJfec7f542d3f149ddb920a8ada25386b8 DE-627 ger DE-627 rakwb eng RC254-282 Linda A. J. Hendricks verfasserin aut Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS) 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data were collected via patient questionnaires (July 2020–March 2023) and genetic diagnoses from medical files. Associations between lifestyle and breast cancer were calculated using logistic regression corrected for age. Index patients with breast cancer before PHTS diagnosis (breast cancer index) were excluded for ascertainment bias correction. In total, 125 patients were included who completed the questionnaire at a mean age of 44 years (SD = 13). This included 21 breast cancer indexes (17%) and 39 females who developed breast cancer at 43 years (SD = 9). Breast cancer patients performed about 1.1 times less often 0–1 times/week physical activity than ≥2 times (OR<sub<total-adj</sub< = 0.9 (95%CI 0.3–2.6); consumed daily about 1.2–1.8 times more often ≥1 than 0–1 glasses of alcohol (OR<sub<total-adj</sub< = 1.2 (95%CI 0.4–4.0); OR<sub<non-breastcancer-index-adj</sub< = 1.8 (95%CI 0.4–6.9); were about 1.04–1.3 times more often smokers than non-smokers (OR<sub<total-adj</sub< = 1.04 (95%CI 0.4–2.8); OR<sub<non-breastcancer-index-adj</sub< = 1.3 (95%CI 0.4–4.2)); and overweight or obesity (72%) was about 1.02–1.3 times less common (OR<sub<total-adj</sub< = 0.98 (95%CI 0.4–2.6); OR<sub<non-breastcancer-index-adj</sub< = 0.8 (95%CI 0.3–2.7)). Similar associations between lifestyle and breast cancer are suggested for PHTS and the general population. Despite not being statistically significant, results are clinically relevant and suggest that awareness of the effects of lifestyle on patients’ breast cancer risk is important. alcohol drinking body mass index breast neoplasm exercise hamartoma syndrome multiple Neoplasms. Tumors. Oncology. Including cancer and carcinogens Katja C. J. Verbeek verfasserin aut Janneke H. M. Schuurs-Hoeijmakers verfasserin aut Arjen R. Mensenkamp verfasserin aut Hilde Brems verfasserin aut Robin de Putter verfasserin aut Violetta C. Anastasiadou verfasserin aut Marie-Charlotte Villy verfasserin aut Arne Jahn verfasserin aut Verena Steinke-Lange verfasserin aut Margherita Baldassarri verfasserin aut Arvids Irmejs verfasserin aut Mirjam M. de Jong verfasserin aut Thera P. Links verfasserin aut Edward M. Leter verfasserin aut Daniëlle G. M. Bosch verfasserin aut Hildegunn Høberg-Vetti verfasserin aut Marianne Tveit Haavind verfasserin aut Kjersti Jørgensen verfasserin aut Lovise Mæhle verfasserin aut Ana Blatnik verfasserin aut Joan Brunet verfasserin aut Esther Darder verfasserin aut Emma Tham verfasserin aut Nicoline Hoogerbrugge verfasserin aut Janet R. Vos verfasserin aut In Cancers MDPI AG, 2010 16(2024), 5, p 953 (DE-627)614095670 (DE-600)2527080-1 20726694 nnns volume:16 year:2024 number:5, p 953 https://doi.org/10.3390/cancers16050953 kostenfrei https://doaj.org/article/fec7f542d3f149ddb920a8ada25386b8 kostenfrei https://www.mdpi.com/2072-6694/16/5/953 kostenfrei https://doaj.org/toc/2072-6694 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 16 2024 5, p 953 |
allfieldsGer |
10.3390/cancers16050953 doi (DE-627)DOAJ091272653 (DE-599)DOAJfec7f542d3f149ddb920a8ada25386b8 DE-627 ger DE-627 rakwb eng RC254-282 Linda A. J. Hendricks verfasserin aut Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS) 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data were collected via patient questionnaires (July 2020–March 2023) and genetic diagnoses from medical files. Associations between lifestyle and breast cancer were calculated using logistic regression corrected for age. Index patients with breast cancer before PHTS diagnosis (breast cancer index) were excluded for ascertainment bias correction. In total, 125 patients were included who completed the questionnaire at a mean age of 44 years (SD = 13). This included 21 breast cancer indexes (17%) and 39 females who developed breast cancer at 43 years (SD = 9). Breast cancer patients performed about 1.1 times less often 0–1 times/week physical activity than ≥2 times (OR<sub<total-adj</sub< = 0.9 (95%CI 0.3–2.6); consumed daily about 1.2–1.8 times more often ≥1 than 0–1 glasses of alcohol (OR<sub<total-adj</sub< = 1.2 (95%CI 0.4–4.0); OR<sub<non-breastcancer-index-adj</sub< = 1.8 (95%CI 0.4–6.9); were about 1.04–1.3 times more often smokers than non-smokers (OR<sub<total-adj</sub< = 1.04 (95%CI 0.4–2.8); OR<sub<non-breastcancer-index-adj</sub< = 1.3 (95%CI 0.4–4.2)); and overweight or obesity (72%) was about 1.02–1.3 times less common (OR<sub<total-adj</sub< = 0.98 (95%CI 0.4–2.6); OR<sub<non-breastcancer-index-adj</sub< = 0.8 (95%CI 0.3–2.7)). Similar associations between lifestyle and breast cancer are suggested for PHTS and the general population. Despite not being statistically significant, results are clinically relevant and suggest that awareness of the effects of lifestyle on patients’ breast cancer risk is important. alcohol drinking body mass index breast neoplasm exercise hamartoma syndrome multiple Neoplasms. Tumors. Oncology. Including cancer and carcinogens Katja C. J. Verbeek verfasserin aut Janneke H. M. Schuurs-Hoeijmakers verfasserin aut Arjen R. Mensenkamp verfasserin aut Hilde Brems verfasserin aut Robin de Putter verfasserin aut Violetta C. Anastasiadou verfasserin aut Marie-Charlotte Villy verfasserin aut Arne Jahn verfasserin aut Verena Steinke-Lange verfasserin aut Margherita Baldassarri verfasserin aut Arvids Irmejs verfasserin aut Mirjam M. de Jong verfasserin aut Thera P. Links verfasserin aut Edward M. Leter verfasserin aut Daniëlle G. M. Bosch verfasserin aut Hildegunn Høberg-Vetti verfasserin aut Marianne Tveit Haavind verfasserin aut Kjersti Jørgensen verfasserin aut Lovise Mæhle verfasserin aut Ana Blatnik verfasserin aut Joan Brunet verfasserin aut Esther Darder verfasserin aut Emma Tham verfasserin aut Nicoline Hoogerbrugge verfasserin aut Janet R. Vos verfasserin aut In Cancers MDPI AG, 2010 16(2024), 5, p 953 (DE-627)614095670 (DE-600)2527080-1 20726694 nnns volume:16 year:2024 number:5, p 953 https://doi.org/10.3390/cancers16050953 kostenfrei https://doaj.org/article/fec7f542d3f149ddb920a8ada25386b8 kostenfrei https://www.mdpi.com/2072-6694/16/5/953 kostenfrei https://doaj.org/toc/2072-6694 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 16 2024 5, p 953 |
allfieldsSound |
10.3390/cancers16050953 doi (DE-627)DOAJ091272653 (DE-599)DOAJfec7f542d3f149ddb920a8ada25386b8 DE-627 ger DE-627 rakwb eng RC254-282 Linda A. J. Hendricks verfasserin aut Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS) 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data were collected via patient questionnaires (July 2020–March 2023) and genetic diagnoses from medical files. Associations between lifestyle and breast cancer were calculated using logistic regression corrected for age. Index patients with breast cancer before PHTS diagnosis (breast cancer index) were excluded for ascertainment bias correction. In total, 125 patients were included who completed the questionnaire at a mean age of 44 years (SD = 13). This included 21 breast cancer indexes (17%) and 39 females who developed breast cancer at 43 years (SD = 9). Breast cancer patients performed about 1.1 times less often 0–1 times/week physical activity than ≥2 times (OR<sub<total-adj</sub< = 0.9 (95%CI 0.3–2.6); consumed daily about 1.2–1.8 times more often ≥1 than 0–1 glasses of alcohol (OR<sub<total-adj</sub< = 1.2 (95%CI 0.4–4.0); OR<sub<non-breastcancer-index-adj</sub< = 1.8 (95%CI 0.4–6.9); were about 1.04–1.3 times more often smokers than non-smokers (OR<sub<total-adj</sub< = 1.04 (95%CI 0.4–2.8); OR<sub<non-breastcancer-index-adj</sub< = 1.3 (95%CI 0.4–4.2)); and overweight or obesity (72%) was about 1.02–1.3 times less common (OR<sub<total-adj</sub< = 0.98 (95%CI 0.4–2.6); OR<sub<non-breastcancer-index-adj</sub< = 0.8 (95%CI 0.3–2.7)). Similar associations between lifestyle and breast cancer are suggested for PHTS and the general population. Despite not being statistically significant, results are clinically relevant and suggest that awareness of the effects of lifestyle on patients’ breast cancer risk is important. alcohol drinking body mass index breast neoplasm exercise hamartoma syndrome multiple Neoplasms. Tumors. Oncology. Including cancer and carcinogens Katja C. J. Verbeek verfasserin aut Janneke H. M. Schuurs-Hoeijmakers verfasserin aut Arjen R. Mensenkamp verfasserin aut Hilde Brems verfasserin aut Robin de Putter verfasserin aut Violetta C. Anastasiadou verfasserin aut Marie-Charlotte Villy verfasserin aut Arne Jahn verfasserin aut Verena Steinke-Lange verfasserin aut Margherita Baldassarri verfasserin aut Arvids Irmejs verfasserin aut Mirjam M. de Jong verfasserin aut Thera P. Links verfasserin aut Edward M. Leter verfasserin aut Daniëlle G. M. Bosch verfasserin aut Hildegunn Høberg-Vetti verfasserin aut Marianne Tveit Haavind verfasserin aut Kjersti Jørgensen verfasserin aut Lovise Mæhle verfasserin aut Ana Blatnik verfasserin aut Joan Brunet verfasserin aut Esther Darder verfasserin aut Emma Tham verfasserin aut Nicoline Hoogerbrugge verfasserin aut Janet R. Vos verfasserin aut In Cancers MDPI AG, 2010 16(2024), 5, p 953 (DE-627)614095670 (DE-600)2527080-1 20726694 nnns volume:16 year:2024 number:5, p 953 https://doi.org/10.3390/cancers16050953 kostenfrei https://doaj.org/article/fec7f542d3f149ddb920a8ada25386b8 kostenfrei https://www.mdpi.com/2072-6694/16/5/953 kostenfrei https://doaj.org/toc/2072-6694 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 16 2024 5, p 953 |
language |
English |
source |
In Cancers 16(2024), 5, p 953 volume:16 year:2024 number:5, p 953 |
sourceStr |
In Cancers 16(2024), 5, p 953 volume:16 year:2024 number:5, p 953 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
alcohol drinking body mass index breast neoplasm exercise hamartoma syndrome multiple Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
isfreeaccess_bool |
true |
container_title |
Cancers |
authorswithroles_txt_mv |
Linda A. J. Hendricks @@aut@@ Katja C. J. Verbeek @@aut@@ Janneke H. M. Schuurs-Hoeijmakers @@aut@@ Arjen R. Mensenkamp @@aut@@ Hilde Brems @@aut@@ Robin de Putter @@aut@@ Violetta C. Anastasiadou @@aut@@ Marie-Charlotte Villy @@aut@@ Arne Jahn @@aut@@ Verena Steinke-Lange @@aut@@ Margherita Baldassarri @@aut@@ Arvids Irmejs @@aut@@ Mirjam M. de Jong @@aut@@ Thera P. Links @@aut@@ Edward M. Leter @@aut@@ Daniëlle G. M. Bosch @@aut@@ Hildegunn Høberg-Vetti @@aut@@ Marianne Tveit Haavind @@aut@@ Kjersti Jørgensen @@aut@@ Lovise Mæhle @@aut@@ Ana Blatnik @@aut@@ Joan Brunet @@aut@@ Esther Darder @@aut@@ Emma Tham @@aut@@ Nicoline Hoogerbrugge @@aut@@ Janet R. Vos @@aut@@ |
publishDateDaySort_date |
2024-01-01T00:00:00Z |
hierarchy_top_id |
614095670 |
id |
DOAJ091272653 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ091272653</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413232928.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240412s2024 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/cancers16050953</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ091272653</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJfec7f542d3f149ddb920a8ada25386b8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC254-282</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Linda A. J. Hendricks</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2024</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data were collected via patient questionnaires (July 2020–March 2023) and genetic diagnoses from medical files. Associations between lifestyle and breast cancer were calculated using logistic regression corrected for age. Index patients with breast cancer before PHTS diagnosis (breast cancer index) were excluded for ascertainment bias correction. In total, 125 patients were included who completed the questionnaire at a mean age of 44 years (SD = 13). This included 21 breast cancer indexes (17%) and 39 females who developed breast cancer at 43 years (SD = 9). Breast cancer patients performed about 1.1 times less often 0–1 times/week physical activity than ≥2 times (OR<sub<total-adj</sub< = 0.9 (95%CI 0.3–2.6); consumed daily about 1.2–1.8 times more often ≥1 than 0–1 glasses of alcohol (OR<sub<total-adj</sub< = 1.2 (95%CI 0.4–4.0); OR<sub<non-breastcancer-index-adj</sub< = 1.8 (95%CI 0.4–6.9); were about 1.04–1.3 times more often smokers than non-smokers (OR<sub<total-adj</sub< = 1.04 (95%CI 0.4–2.8); OR<sub<non-breastcancer-index-adj</sub< = 1.3 (95%CI 0.4–4.2)); and overweight or obesity (72%) was about 1.02–1.3 times less common (OR<sub<total-adj</sub< = 0.98 (95%CI 0.4–2.6); OR<sub<non-breastcancer-index-adj</sub< = 0.8 (95%CI 0.3–2.7)). Similar associations between lifestyle and breast cancer are suggested for PHTS and the general population. Despite not being statistically significant, results are clinically relevant and suggest that awareness of the effects of lifestyle on patients’ breast cancer risk is important.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">alcohol drinking</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">body mass index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">breast neoplasm</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">exercise</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hamartoma syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">multiple</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Katja C. J. Verbeek</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Janneke H. M. Schuurs-Hoeijmakers</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Arjen R. Mensenkamp</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hilde Brems</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Robin de Putter</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Violetta C. Anastasiadou</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marie-Charlotte Villy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Arne Jahn</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Verena Steinke-Lange</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Margherita Baldassarri</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Arvids Irmejs</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Mirjam M. de Jong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Thera P. Links</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Edward M. Leter</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Daniëlle G. M. Bosch</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hildegunn Høberg-Vetti</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marianne Tveit Haavind</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kjersti Jørgensen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lovise Mæhle</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ana Blatnik</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Joan Brunet</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Esther Darder</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Emma Tham</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nicoline Hoogerbrugge</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Janet R. Vos</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Cancers</subfield><subfield code="d">MDPI AG, 2010</subfield><subfield code="g">16(2024), 5, p 953</subfield><subfield code="w">(DE-627)614095670</subfield><subfield code="w">(DE-600)2527080-1</subfield><subfield code="x">20726694</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:16</subfield><subfield code="g">year:2024</subfield><subfield code="g">number:5, p 953</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/cancers16050953</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/fec7f542d3f149ddb920a8ada25386b8</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2072-6694/16/5/953</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2072-6694</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">16</subfield><subfield code="j">2024</subfield><subfield code="e">5, p 953</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Linda A. J. Hendricks |
spellingShingle |
Linda A. J. Hendricks misc RC254-282 misc alcohol drinking misc body mass index misc breast neoplasm misc exercise misc hamartoma syndrome misc multiple misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS) |
authorStr |
Linda A. J. Hendricks |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)614095670 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RC254-282 |
illustrated |
Not Illustrated |
issn |
20726694 |
topic_title |
RC254-282 Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS) alcohol drinking body mass index breast neoplasm exercise hamartoma syndrome multiple |
topic |
misc RC254-282 misc alcohol drinking misc body mass index misc breast neoplasm misc exercise misc hamartoma syndrome misc multiple misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
topic_unstemmed |
misc RC254-282 misc alcohol drinking misc body mass index misc breast neoplasm misc exercise misc hamartoma syndrome misc multiple misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
topic_browse |
misc RC254-282 misc alcohol drinking misc body mass index misc breast neoplasm misc exercise misc hamartoma syndrome misc multiple misc Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Cancers |
hierarchy_parent_id |
614095670 |
hierarchy_top_title |
Cancers |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)614095670 (DE-600)2527080-1 |
title |
Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS) |
ctrlnum |
(DE-627)DOAJ091272653 (DE-599)DOAJfec7f542d3f149ddb920a8ada25386b8 |
title_full |
Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS) |
author_sort |
Linda A. J. Hendricks |
journal |
Cancers |
journalStr |
Cancers |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2024 |
contenttype_str_mv |
txt |
author_browse |
Linda A. J. Hendricks Katja C. J. Verbeek Janneke H. M. Schuurs-Hoeijmakers Arjen R. Mensenkamp Hilde Brems Robin de Putter Violetta C. Anastasiadou Marie-Charlotte Villy Arne Jahn Verena Steinke-Lange Margherita Baldassarri Arvids Irmejs Mirjam M. de Jong Thera P. Links Edward M. Leter Daniëlle G. M. Bosch Hildegunn Høberg-Vetti Marianne Tveit Haavind Kjersti Jørgensen Lovise Mæhle Ana Blatnik Joan Brunet Esther Darder Emma Tham Nicoline Hoogerbrugge Janet R. Vos |
container_volume |
16 |
class |
RC254-282 |
format_se |
Elektronische Aufsätze |
author-letter |
Linda A. J. Hendricks |
doi_str_mv |
10.3390/cancers16050953 |
author2-role |
verfasserin |
title_sort |
lifestyle factors and breast cancer in females with pten hamartoma tumor syndrome (phts) |
callnumber |
RC254-282 |
title_auth |
Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS) |
abstract |
Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data were collected via patient questionnaires (July 2020–March 2023) and genetic diagnoses from medical files. Associations between lifestyle and breast cancer were calculated using logistic regression corrected for age. Index patients with breast cancer before PHTS diagnosis (breast cancer index) were excluded for ascertainment bias correction. In total, 125 patients were included who completed the questionnaire at a mean age of 44 years (SD = 13). This included 21 breast cancer indexes (17%) and 39 females who developed breast cancer at 43 years (SD = 9). Breast cancer patients performed about 1.1 times less often 0–1 times/week physical activity than ≥2 times (OR<sub<total-adj</sub< = 0.9 (95%CI 0.3–2.6); consumed daily about 1.2–1.8 times more often ≥1 than 0–1 glasses of alcohol (OR<sub<total-adj</sub< = 1.2 (95%CI 0.4–4.0); OR<sub<non-breastcancer-index-adj</sub< = 1.8 (95%CI 0.4–6.9); were about 1.04–1.3 times more often smokers than non-smokers (OR<sub<total-adj</sub< = 1.04 (95%CI 0.4–2.8); OR<sub<non-breastcancer-index-adj</sub< = 1.3 (95%CI 0.4–4.2)); and overweight or obesity (72%) was about 1.02–1.3 times less common (OR<sub<total-adj</sub< = 0.98 (95%CI 0.4–2.6); OR<sub<non-breastcancer-index-adj</sub< = 0.8 (95%CI 0.3–2.7)). Similar associations between lifestyle and breast cancer are suggested for PHTS and the general population. Despite not being statistically significant, results are clinically relevant and suggest that awareness of the effects of lifestyle on patients’ breast cancer risk is important. |
abstractGer |
Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data were collected via patient questionnaires (July 2020–March 2023) and genetic diagnoses from medical files. Associations between lifestyle and breast cancer were calculated using logistic regression corrected for age. Index patients with breast cancer before PHTS diagnosis (breast cancer index) were excluded for ascertainment bias correction. In total, 125 patients were included who completed the questionnaire at a mean age of 44 years (SD = 13). This included 21 breast cancer indexes (17%) and 39 females who developed breast cancer at 43 years (SD = 9). Breast cancer patients performed about 1.1 times less often 0–1 times/week physical activity than ≥2 times (OR<sub<total-adj</sub< = 0.9 (95%CI 0.3–2.6); consumed daily about 1.2–1.8 times more often ≥1 than 0–1 glasses of alcohol (OR<sub<total-adj</sub< = 1.2 (95%CI 0.4–4.0); OR<sub<non-breastcancer-index-adj</sub< = 1.8 (95%CI 0.4–6.9); were about 1.04–1.3 times more often smokers than non-smokers (OR<sub<total-adj</sub< = 1.04 (95%CI 0.4–2.8); OR<sub<non-breastcancer-index-adj</sub< = 1.3 (95%CI 0.4–4.2)); and overweight or obesity (72%) was about 1.02–1.3 times less common (OR<sub<total-adj</sub< = 0.98 (95%CI 0.4–2.6); OR<sub<non-breastcancer-index-adj</sub< = 0.8 (95%CI 0.3–2.7)). Similar associations between lifestyle and breast cancer are suggested for PHTS and the general population. Despite not being statistically significant, results are clinically relevant and suggest that awareness of the effects of lifestyle on patients’ breast cancer risk is important. |
abstract_unstemmed |
Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data were collected via patient questionnaires (July 2020–March 2023) and genetic diagnoses from medical files. Associations between lifestyle and breast cancer were calculated using logistic regression corrected for age. Index patients with breast cancer before PHTS diagnosis (breast cancer index) were excluded for ascertainment bias correction. In total, 125 patients were included who completed the questionnaire at a mean age of 44 years (SD = 13). This included 21 breast cancer indexes (17%) and 39 females who developed breast cancer at 43 years (SD = 9). Breast cancer patients performed about 1.1 times less often 0–1 times/week physical activity than ≥2 times (OR<sub<total-adj</sub< = 0.9 (95%CI 0.3–2.6); consumed daily about 1.2–1.8 times more often ≥1 than 0–1 glasses of alcohol (OR<sub<total-adj</sub< = 1.2 (95%CI 0.4–4.0); OR<sub<non-breastcancer-index-adj</sub< = 1.8 (95%CI 0.4–6.9); were about 1.04–1.3 times more often smokers than non-smokers (OR<sub<total-adj</sub< = 1.04 (95%CI 0.4–2.8); OR<sub<non-breastcancer-index-adj</sub< = 1.3 (95%CI 0.4–4.2)); and overweight or obesity (72%) was about 1.02–1.3 times less common (OR<sub<total-adj</sub< = 0.98 (95%CI 0.4–2.6); OR<sub<non-breastcancer-index-adj</sub< = 0.8 (95%CI 0.3–2.7)). Similar associations between lifestyle and breast cancer are suggested for PHTS and the general population. Despite not being statistically significant, results are clinically relevant and suggest that awareness of the effects of lifestyle on patients’ breast cancer risk is important. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
5, p 953 |
title_short |
Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS) |
url |
https://doi.org/10.3390/cancers16050953 https://doaj.org/article/fec7f542d3f149ddb920a8ada25386b8 https://www.mdpi.com/2072-6694/16/5/953 https://doaj.org/toc/2072-6694 |
remote_bool |
true |
author2 |
Katja C. J. Verbeek Janneke H. M. Schuurs-Hoeijmakers Arjen R. Mensenkamp Hilde Brems Robin de Putter Violetta C. Anastasiadou Marie-Charlotte Villy Arne Jahn Verena Steinke-Lange Margherita Baldassarri Arvids Irmejs Mirjam M. de Jong Thera P. Links Edward M. Leter Daniëlle G. M. Bosch Hildegunn Høberg-Vetti Marianne Tveit Haavind Kjersti Jørgensen Lovise Mæhle Ana Blatnik Joan Brunet Esther Darder Emma Tham Nicoline Hoogerbrugge Janet R. Vos |
author2Str |
Katja C. J. Verbeek Janneke H. M. Schuurs-Hoeijmakers Arjen R. Mensenkamp Hilde Brems Robin de Putter Violetta C. Anastasiadou Marie-Charlotte Villy Arne Jahn Verena Steinke-Lange Margherita Baldassarri Arvids Irmejs Mirjam M. de Jong Thera P. Links Edward M. Leter Daniëlle G. M. Bosch Hildegunn Høberg-Vetti Marianne Tveit Haavind Kjersti Jørgensen Lovise Mæhle Ana Blatnik Joan Brunet Esther Darder Emma Tham Nicoline Hoogerbrugge Janet R. Vos |
ppnlink |
614095670 |
callnumber-subject |
RC - Internal Medicine |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.3390/cancers16050953 |
callnumber-a |
RC254-282 |
up_date |
2024-07-03T19:29:54.813Z |
_version_ |
1803587414728376320 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ091272653</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413232928.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240412s2024 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/cancers16050953</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ091272653</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJfec7f542d3f149ddb920a8ada25386b8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC254-282</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Linda A. J. Hendricks</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2024</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data were collected via patient questionnaires (July 2020–March 2023) and genetic diagnoses from medical files. Associations between lifestyle and breast cancer were calculated using logistic regression corrected for age. Index patients with breast cancer before PHTS diagnosis (breast cancer index) were excluded for ascertainment bias correction. In total, 125 patients were included who completed the questionnaire at a mean age of 44 years (SD = 13). This included 21 breast cancer indexes (17%) and 39 females who developed breast cancer at 43 years (SD = 9). Breast cancer patients performed about 1.1 times less often 0–1 times/week physical activity than ≥2 times (OR<sub<total-adj</sub< = 0.9 (95%CI 0.3–2.6); consumed daily about 1.2–1.8 times more often ≥1 than 0–1 glasses of alcohol (OR<sub<total-adj</sub< = 1.2 (95%CI 0.4–4.0); OR<sub<non-breastcancer-index-adj</sub< = 1.8 (95%CI 0.4–6.9); were about 1.04–1.3 times more often smokers than non-smokers (OR<sub<total-adj</sub< = 1.04 (95%CI 0.4–2.8); OR<sub<non-breastcancer-index-adj</sub< = 1.3 (95%CI 0.4–4.2)); and overweight or obesity (72%) was about 1.02–1.3 times less common (OR<sub<total-adj</sub< = 0.98 (95%CI 0.4–2.6); OR<sub<non-breastcancer-index-adj</sub< = 0.8 (95%CI 0.3–2.7)). Similar associations between lifestyle and breast cancer are suggested for PHTS and the general population. Despite not being statistically significant, results are clinically relevant and suggest that awareness of the effects of lifestyle on patients’ breast cancer risk is important.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">alcohol drinking</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">body mass index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">breast neoplasm</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">exercise</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hamartoma syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">multiple</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Katja C. J. Verbeek</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Janneke H. M. Schuurs-Hoeijmakers</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Arjen R. Mensenkamp</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hilde Brems</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Robin de Putter</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Violetta C. Anastasiadou</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marie-Charlotte Villy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Arne Jahn</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Verena Steinke-Lange</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Margherita Baldassarri</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Arvids Irmejs</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Mirjam M. de Jong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Thera P. Links</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Edward M. Leter</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Daniëlle G. M. Bosch</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hildegunn Høberg-Vetti</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marianne Tveit Haavind</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kjersti Jørgensen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Lovise Mæhle</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ana Blatnik</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Joan Brunet</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Esther Darder</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Emma Tham</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nicoline Hoogerbrugge</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Janet R. Vos</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Cancers</subfield><subfield code="d">MDPI AG, 2010</subfield><subfield code="g">16(2024), 5, p 953</subfield><subfield code="w">(DE-627)614095670</subfield><subfield code="w">(DE-600)2527080-1</subfield><subfield code="x">20726694</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:16</subfield><subfield code="g">year:2024</subfield><subfield code="g">number:5, p 953</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/cancers16050953</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/fec7f542d3f149ddb920a8ada25386b8</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2072-6694/16/5/953</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2072-6694</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">16</subfield><subfield code="j">2024</subfield><subfield code="e">5, p 953</subfield></datafield></record></collection>
|
score |
7.3978424 |